Dr. Hutter: Hello. Welcome to Conversations with Experts; I'm Dolph Hutter. Today we're talking about "Clopidogrel Resistance: Its Significance and Management." With me is Dr. Gilles Montalescot ...

For their study, Saibal Das, a research scholar at the Indian Council of Medical Research Centre for Ageing and Mental Health ...

The clopidogrel-rivaroxaban combination significantly reduced the risk of composite ... Data were extracted from electronic medical records, including patient demographics, comorbidities, renal ...

Until you have been through a health condition that sapped your energy, drained your pockets and made people hardly recognise ...

The Annals of Pharmacotherapy. 2008;42(6):790-805.

Results: A total of 472 patients will be enrolled. Patients will be randomized (1:1) to drug-eluting stenting plus medical therapy or medical therapy alone. Medical treatment includes dual ...

Melvin Mann, diagnosed with chronic myeloid leukemia in 1994, participated in a clinical trial for Imatinib that extended his ...

By his estimate, that means AI has been around at Sanofi for about a third of the "discovery" process for some drugs. That process is when manufacturers figure out what compounds ...

Prescription drugs can be administered in various ways. This includes oral (by mouth), enteral (into the gastrointestinal tract), mucosal (through a mucus membrane), and percutaneous (through the skin ...

Delta4 receives European patents for two compounds as candidate treatments for focal segmental glomerulosclerosis: Vienna, Austria Monday, February 3, 2025, 18:00 Hrs [IST] Delta4 ...

Low-dose antiplatelet drugs had a lower risk of bleeding compared to standard doses. Still, efficacy and safety in terms of stroke, MI, ACD, major bleeding, and bleeding leading to discontinuation ...